Pfizer (PFE)

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-04-23 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: PFIZER INC (PFE) CIK: 0000078003 --- Reporting Owner --- Name: NARAYEN SHANTANU CIK: 0001224154 Role: Director --- Derivative Transactions --- [Transaction #1] Security: Phantom Stock Units Date: 2026-04-23 | Code: A (Grant or award) Shares: +7,686.539 | Price: $26.67 Shares Owned After: 195,611.68 | Ownership: D (Direct) Footnotes: [F1] Each unit represents one phantom share of common stock. [F2] Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. [F3] These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors. [F3] These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors. --- Footnotes (Complete Index) --- F1: Each unit represents one phantom share of common stock. F2: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors. --- Signature --- /s/ /s/ Shanice A. Reid, by power of atty., for Shantanu Narayen (2026-04-27)